Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

3.29
+0.23007.52%
Post-market: 3.290.00000.00%19:09 EDT
Volume:1.14M
Turnover:3.68M
Market Cap:348.83M
PE:-8.40
High:3.32
Open:3.10
Low:3.02
Close:3.06
Loading ...

Company Profile

Company Name:
MaxCyte Inc
Exchange:
NASDAQ
Establishment Date:
1998
Employees:
114
Office Location:
9713 Key West Avenue,Suite 400,Rockville,Maryland,United States
Zip Code:
20850
Fax:
- -
Introduction:
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Directors

Name
Position
Doug Doerfler
Director,president and chief executive officer
Art Mandell
Director
John Johnston
Director
Rekha Hemrajani
Director
Richard H. Douglas
Director
Stanley C. Erck
Director
Will Brooke
Director
Yasir Al Wakeel
Director

Shareholders

Name
Position
Amanda Murphy
Chief Financial Officer
Ron Holtz
Senior Vice President and Chief Accounting Officer
Doug Doerfler
Director,president and chief executive officer
Maher Masoud
Executive Vice President, General Counsel and Secretary
Thomas M. Ross
Executive Vice President, Global Sales